Glucosuria as a Biomarker of Adherence to Sodium-Glucose Co-Transporter Protein Type 2 Inhibitors
Absent glucosuria could be an easy biomarker of poor adherence in patients treated with SGLT2i in clinical practice.
Authors
- E. Jiménez-Varo
- Ana Lopez-Ceres
- A. Hormigo-Pozo
- M. Escribano-Cobalea
- C. Casto-Jarillo
- E. Campos-Dávila
- Josep Franch-Nadal
- José Escribano-Serrano
- Alfredo Michán-Doña
Institutions
- Hospital Regional de Concepción (CL)
- Biomedical Research and Innovation Institute of Cadiz (ES)
- Institut Universitari d'Investigació en Atenció Primària Jordi Gol (ES)
- Hospital Universitario Puerta del Mar (ES)
- Centro de Física Miguel Antonio Catalán (ES)
- Institut Català de la Salut (ES)
- Universidad de Málaga (ES)
Publication Details
- Journal
- Patient Preference and Adherence
- Published
- 2026-02-01
- DOI
- https://doi.org/10.2147/ppa.s576212
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00